FDA Releases Guidance for Digital Health Tech Used in Clinical Investigations
FDA Proposes Risk-Based and Remote Inspection Strategies in New Report
Breaking Down FDA’s New Remote Monitoring Strategy
FDA Announces Facility Fees for OTC Drug Manufacturers
FDA Update: The Latest on Vaccine Development, Inspections, and Conducting Clinical Trials During Covid-19
FDA Announces Plans to Resume Domestic On-site Inspections
FDA Issue Guidance on Manufacturing Drugs, APIs during COVID-19
Navigating FDA Policies for PPE, and Liability Protections
Going Virtual: Clinical Trials, Telemedicine, Electronic Medical Records, And All That.
FDA Updates Policy to Curb Unreliable COVID-19 Antibody Tests
Upping Hospitals’ Liability Defenses For COVID Measures
April 16 Update: Key FDA Actions for COVID-19 Devices and Therapies
Update: Key FDA Actions for COVID-19 Devices and Therapies
Personal Protective Equipment & Ventilators: How FDA Is Increasing Supply for the US Healthcare System
Subscribe: Subscribe via RSS